Dr. Sinjini Sarkar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Checkpoint Genes in Check: Impact of BUB1, BUB1B, and MAD2 Alterations on the Treatment Outcomes of Advanced Ovarian Cancer
  Journal of Current Oncological Trends 2025 DOI: 10.4103/jcot.jcot_2_25
  +Save
• Clinicopathological insights and prognostic implications of DEK in association with apoptosis-regulating factors in ovarian cancer
  Clinical and Translational Oncology 2025 DOI: 10.1007/s12094-025-03944-8
  +Save
• Implication of microRNA-regulated PTEN expression in the clinico-pathology & survival outcomes in advanced ovarian cancer
  Indian Journal of Medical Research 2025 DOI: 10.25259/IJMR_1045_2024
  +Save
• Nanocarrier in Gene Therapy
  Nanocarriers for Nucleic Acids and Proteins 2025 DOI: 10.1201/9781003473183-13
  +Save
• Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target
  Naunyn Schmiedeberg S Archives of Pharmacology 2025 DOI: 10.1007/s00210-024-03595-6
  +Save
• Nanocarrier in Gene Therapy
  Nanocarriers for Nucleic Acids and Proteins 2025 DOI: 10.1201/9781003473183-13
  +Save
• Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target
  2024
  +Save
• Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study
  Journal of Cancer Research and Therapeutics 2024 DOI: 10.4103/jcrt.jcrt_2179_22
  +Save
• Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle‑assembly Checkpoint
  Indian Journal of Public Health 2024 DOI: 10.4103/ijph.ijph_809_23
  +Save
• Emerging Futuristic Targeted Therapeutics
  American Journal of Clinical Oncology 2023 DOI: 10.1097/coc.0000000000001071
  +Save